Skip to search formSkip to main contentSkip to account menu

ciclonicate

Known as: 3,5,5-trimethylcyclohexylnicotinate, cyclonicate 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Nicotinic Acids

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
[Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
1984
1984
Ciclonicate in the atherosclerotic vascular disease of the lower limbs
1983
1983
Treatment of peripheral arterial disease: double-blind clinical and instrumental evaluation of ciclonicate vs. placebo
1983
1983
[Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
1982
1982
[Clinical evaluation of cyclonicate in atherosclerotic coronary arteriopathy].
1982
1982
[Treatment of arteriosclerotic peripheral vascular diseases with ciclonicate].
1981
1981
Long-lasting antilipolytic action of cyclonicate in rats.
1981
1981
Effect of cyclonicate, a new hypolipemic drug, on lipolysis in vitro.
A new hypolipemic drug, cyclonicate (3,3,5-trimethyl-cyclohexyl nicotinate), was studied and its effects were compared with those…